Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
470 participants
OBSERVATIONAL
2024-11-20
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
NCT05563090
The Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City
NCT00308672
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
NCT07248371
Novel Chinese Medicine Formula for Diabetes
NCT06978023
TCM and Nutrition for Diabetes Care Cohort
NCT05312450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cross-sectional observational study
This is a cross-sectional observational study. No intervention will be given.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (2) Diagnosed with Type 2 diabetes.
* (3) Diagnosed with Metabolic Syndrome according to Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) from Chinese Diabetes Society. People who meet 3 of the following diagnostic criteria or more can be diagnosed as Metabolic Syndrome: (a) Abdominal obesity: waist circumference ≥ 90cm for male and ≥ 85cm for female; (b) Hyperglycemia: Fasting blood glucose ≥ 6.1mmol/L or 2-hour postprandial glucose ≥ 7.8mmol/L and/or those who have been diagnosed with hyperglycemia and in treatment; (c) Hypertension: blood pressure ≥ 130/85mmHg and/or those who have been diagnosed with hypertension and in treatment; (d) Fasting triglyceride ≥ 1.70mmol/L; (e) Fasting HDL-C \< 1.04mmol/L.
* (4) Clearly understand the content of the study and voluntarily sign the informed consent form.
* (5) Provide complete data (basic information, TCM diagnosis data, and blood test results).
Exclusion Criteria
* (2) Diabetes accompanied by severe complications such as diabetic nephropathy, diabetic ketoacidosis, etc.
* (3) Secondary obesity (e.g., secondary to pituitary inflammation, tumor, etc.).
* (4) Secondary hypertension (e.g., pheochromocytoma, renal hypertension, etc.).
* (5) Secondary hyperlipidemia (e.g., hypothyroidism, nephrotic syndrome, etc.).
* (6) With severe heart, liver, or kidney disease or bleeding disorders, or with other serious diseases (e.g. cancer, dementia, etc.).
* (7) With severe mental disorders, speech or hearing impairments.
* (8) Pregnancy or lactation female.
* (9) Currently join other clinical trial.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hong Kong Baptist University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ZHANG Jialing
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jialing ZHANG, PhD
Role: PRINCIPAL_INVESTIGATOR
Hong Kong Baptist University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/23-24/0564
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.